At Walter Reed Army Institute of Research, flexibility has been the watchword of the last 18 months. The team at WRAIR pivoted quickly from other work to focus on developing a vaccine for SARS-CoV-2 as soon as the scientific community had access to the full genome in January 2020.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly reduce deaths from cardiovascular conditions, hospitalizations for heart failure and progression of kidney disease among patients with Type 2 diabetes
The COVID-19 pandemic has underscored VA’s lack of a comprehensive supply chain management program, and agency officials once again defended their progress before Congress.
HIV patients on anti-retroviral therapy are at increased risk for cardiovascular events, heightening the importance of preventive care. Now, new research has found that selection of blood pressure medication is critically important for this group and can have a significant effect on risk of cardiovascular events or even death.
In an effort to get as many COVID-19 shots into arms as possible as quickly as feasible, the military is continuing to supply personnel to help the Federal Emergency Management Agency at mass vaccination sites.
Government medical agencies need to view toxic exposure as a high-priority issue deserving of specialized centers for research and monitoring.
The U.S. Postal Service (USPS) has long been the most popular government institution in the country, but cascading delays in the last eight months have threatened its preferred position as both businesses and individuals suffer from lost and stranded mail and packages.
About one-third of military servicemembers, civilian contractors and military family members are declining to be vaccinated for COVID-19, and that has DoD officials concerned.
About 80 million prescriptions are written in the United States each year for metformin.
The Food and Drug Administration has approved an updated label for the Pfizer-BioNTech vaccine, urging that the sixth dose in vaccine vials be used.
In the chaotic days when the COVID-19 pandemic first began to affect the United States, healthcare professionals were barraged with questions about certain blood pressure medications and whether they increased infection risk for patients using them.
As the pandemic numbers rose last spring, the VA discovered what hospital systems across the country were learning—that the usual supply chains for personal protective equipment (PPE) could not handle the demand, and the gray market was rife with price-gouging and low-quality products.
With all of the testing of complex new therapies to lower severity of COVID-19 infections, a simple and common practice — taking a daily aspirin to protect against cardiovascular disease – has shown some promise.
For academic detailers, acting as change agents is nothing new. It’s central to their work as clinical pharmacy specialists and educators. This year, the academic detailers at the VA found their transformative role included a new and urgent responsibility—increasing provider comfort with telehealth technology.
While use and misuse of opioids by active-duty servicemembers has been examined in several studies, much less is known about use of painkillers by their spouses.
WASHINGTON — Legislators and veterans advocates are concerned about VA’s continued use of hydroxychloroquine, an antimalarial also commonly used to treat rheumatoid arthritis and lupus, on COVID-19 patients.
BETHESDA, MD—Pharmacies throughout the Military Health System have taken steps to protect their customers and staff from exposure to COVID-19 in recent weeks. Many have adopted curbside pickup and expanded drive-thru capacity. Others have adapted their physical...
Potential to Fix Two Huge Problems with the U.S. Healthcare System CAMBRIDGE, MA—Rising drug prices have frustrated patients nationwide, often leading individuals to forgo needed therapies because they simply could not afford them. In some instances, cost-control...